Access Vascular Inc.’s biomaterial-based catheters aim to address complication rates that have long plagued the space. Vascular access complications delay treatment, incur additional risk for patients ...
A peer-reviewed review synthesizes evidence and clinical experience for managing recurrent catheter-related bloodstream ...
Patients who depend on long-term intravenous catheters for chemotherapy, hemodialysis, intravenous nutrition and other ...
BEDFORD, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Access Vascular, Inc. (AVI), a company addressing the most common and costly vascular access complications through its advanced biomaterial platform, ...
A prospective cohort study of 89 cancer patients with superior vena cava syndrome found that tunneled femoral central catheters show low infection and thrombosis rates but a high 23.6 percent ...
In this study, we quantified the risk and described the risk factors for complications associated with arterial catheterization in critically ill children. We already know that central venous ...
The US Food and Drug Administration (FDA) on Wednesday warned healthcare providers of potential harm to patients when neurovascular guide catheters are used to remove blood clots in stroke patients.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results